SGLT2 inhibitors between the zeal of the clinical studies and the challenges of the day-to-day practice

How 2 overcome inertia when it comes to #GDMT in #Heartfailure #dapagliflozin ⁦
⁦@MAb_Card⁩ ⁦@pmhaydock⁩ ⁦@dralicezheng⁩
#gdmt
#GDMT #Heartfailure #dapagliflozin